15-48251703-G-A
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PP5_Moderate
The NM_000338.3(SLC12A1):c.1875G>A(p.Trp625*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000446 in 1,613,608 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000338.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Bartter disease type 1Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- antenatal Bartter syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000338.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC12A1 | NM_000338.3 | MANE Select | c.1875G>A | p.Trp625* | stop_gained | Exon 15 of 27 | NP_000329.2 | ||
| SLC12A1 | NM_001184832.2 | c.1875G>A | p.Trp625* | stop_gained | Exon 15 of 27 | NP_001171761.1 | |||
| SLC12A1 | NM_001384136.1 | c.1875G>A | p.Trp625* | stop_gained | Exon 15 of 27 | NP_001371065.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC12A1 | ENST00000380993.8 | TSL:5 MANE Select | c.1875G>A | p.Trp625* | stop_gained | Exon 15 of 27 | ENSP00000370381.3 | ||
| SLC12A1 | ENST00000558252.5 | TSL:1 | n.5998G>A | non_coding_transcript_exon | Exon 11 of 23 | ||||
| SLC12A1 | ENST00000560692.5 | TSL:1 | n.6014G>A | non_coding_transcript_exon | Exon 10 of 22 |
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152152Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000876 AC: 22AN: 251118 AF XY: 0.0000884 show subpopulations
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461456Hom.: 0 Cov.: 31 AF XY: 0.0000179 AC XY: 13AN XY: 727018 show subpopulations
GnomAD4 genome AF: 0.000315 AC: 48AN: 152152Hom.: 0 Cov.: 32 AF XY: 0.000457 AC XY: 34AN XY: 74332 show subpopulations
ClinVar
Submissions by phenotype
SLC12A1-related disorder Pathogenic:1
The SLC12A1 c.1875G>A variant is predicted to result in premature protein termination (p.Trp625*). This variant was reported in the homozygous state in many Costa Rican patients with antenatal Bartter syndrome and is considered a founder variant in this population (Kurtz et al 1997. PubMed ID: 9355073).This variant is reported in 0.064% of alleles in individuals of Latino descent in gnomAD. Nonsense variants in SLC12A1 are expected to be pathogenic. This variant is interpreted as pathogenic.
Bartter disease type 1 Pathogenic:1
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Trp625*) in the SLC12A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC12A1 are known to be pathogenic (PMID: 8640224, 9585600, 19096086). This variant is present in population databases (rs137853159, gnomAD 0.06%). This premature translational stop signal has been observed in individual(s) with Bartter syndrome (PMID: 9355073). ClinVar contains an entry for this variant (Variation ID: 8754). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at